Skip to main content
OpenTrials

Clinical trial condition

Neoplasms, Plasma Cell

Explore clinical trials studying Neoplasms, Plasma Cell. Study availability and eligibility vary by location and protocol.

2,639 public trials 556 recruiting studies
Refine in advanced search Browse all conditions

Neoplasms, Plasma Cell trial results

Recruiting

A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)

NCT05519085

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +17 more
Locations
  • Local Institution - 0366 Los Alamitos, California, United States
  • Local Institution - 0272 San Diego, California, United States
  • Local Institution - 0273 West Hollywood, California, United States
  • Local Institution - 0381 Aurora, Colorado, United States
View all 266 locations
View Trial Details
Recruiting

A Study of Gammagard Liquid (Immune Globulin Infusion, 10%) to Prevent Infections in Adults With Multiple Myeloma

NCT06980480

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • Infirmary Health - Diagnostic & Medical Clinic (DMC) Mobile, Alabama, United States
  • Chao Family Comprehensive Cancer Center UCI Orange, California, United States
  • University of Kansas Westwood, Kansas, United States
  • University of Maryland | Greenebaum Cancer Center Baltimore, Maryland, United States
View all 56 locations
View Trial Details
Recruiting

A Study of Elranatamab Outpatient Administration in Patients With Relapsed/Refractory Multiple Myeloma

NCT07637578

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +19 more
Locations
  • Colorado Blood Cancer Institute Denver, Colorado, United States
  • Willamette Valley Cancer Institute and Research Center Eugene, Oregon, United States
  • SCRI Oncology Partners Nashville, Tennessee, United States
  • Rocky Mountain Cancer Center Denver, Colorado, United States
View Trial Details
Recruiting

RAT-HEMATO : Return to Work After Malignant Hemopathy

NCT06262789

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +15 more
Locations
  • Angers University hospital Angers, France
  • Brest University Hospital, Morvan Site Brest, France
  • Caen University hospital Caen, France
  • Rennes University Hospital, Pontchaillou site Rennes, France
View Trial Details
Recruiting

A Study Evaluating the Safety and Efficacy of Multiple Treatments in Participants With Multiple Myeloma

NCT05583617

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Prince of Wales Hospital Randwick, New South Wales, Australia
  • St Vincent's Hospital Melbourne Fitzroy, Victoria, Australia
  • CHU Lyon Sud - Service Hématologie Pierre-Bénite, France
  • IUCT Oncopole Toulouse, France
View all 16 locations
View Trial Details
Recruiting

A Study Evaluating the Safety, Pharmacokinetics, and Activity of the Combination of Cevostamab and Elranatamab in Participants With Relapsed or Refractory Multiple Myeloma (R/R MM)

NCT05927571

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +17 more
Locations
  • Royal Prince Alfred Hospital Camperdown, New South Wales, Australia
  • Calvary Mater Newcastle Waratah, New South Wales, Australia
  • Royal Adelaide Hospital;Haematology Clinical Trials Unit Adelaide, South Australia, Australia
  • St. Vincent's Hospital Melbourne Melbourne, Victoria, Australia
View all 14 locations
View Trial Details

Related conditions